1. |
Woodruff SL, Arowolo OA, Akute OO, et al. Global variation in the pattern of differentiated thyroid cancer [J]. Am J Surg, 2010, 200(4): 462466.
|
2. |
Pedersen IB, Laurberg P, Knudsen N, et al. An increased incidence of overt hypothyroidism after iodine fortification of salt in denmark:a prospective population study [J]. J Clin Endocrinol Metab, 2007, 92(8): 31223127.
|
3. |
邊學海, 張廣, 張純海, 等. 甲狀腺乳頭狀癌組織中Shh和Gli1的表達及其臨床意義研究 [J]. 國際外科學雜志, 2011, 38(2): 7881..
|
4. |
Delellis RA. Pathology and genetics of thyroid carcinoma [J]. J Surg Oncol, 2006, 94(8): 662669.
|
5. |
Troviseo V, Soares P, Preto A, et al. Molecular genetics of papillary thyroid carcinoma: great expectations [J]. Arq Bras Endocrinol Metabol, 2007, 51(5): 643653.
|
6. |
任立軍, 楊延芳, 張成雷. 甲狀腺乳頭狀癌淋巴結轉移規律的臨床研究 [J]. 中國普外基礎與臨床雜志, 2011, 18(4): 419422..
|
7. |
于金明, 徐忠法. 腫瘤臨床通鑒 [M]. 濟南: 山東科學技術出版社, 2004: 369375..
|
8. |
Mazzaferri EL, Jhiang SM. Longterm impact of initial surgical and medical therapy on papillary and follicular thyroid cancer [J]. Am J Med, 1994, 97(5): 418428.
|
9. |
吳立剛, 劉奇倫, 胡志強. MMP2和VEGFC在甲狀腺乳頭狀癌中的表達及臨床意義 [J]. 中國普外基礎與臨床雜志, 2009, 16(11): 906910..
|
10. |
袁振芳, 高研, 王薇, 等. γ干擾素對培養的人甲狀腺細胞HLADR抗原基因表達的影響 [J]. 中華內科雜志, 2002, 41(4): 262263..
|
11. |
劉東方, 鄧華聰, 許改平, 等. 人甲狀腺原代細胞的長期培養 [J]. 中華內分泌代謝雜志, 2005, 21(2): 181183..
|
12. |
Jeker LT, Mehrdad H, Lynne BC, et al. Mouse thyroid primary culture [J]. Biochem Biophys Res Commun, 1999, 257(2): 511515.
|
13. |
Antonelli A, Ferrari SM, Fallahi P, et al. Primary cell cultures from anaplastic thyroid cancer obtained by fineneedle aspiration used for chemosensitivity tests [J]. Clin Endocrinol (Oxf), 2008, 69(1): 148152.
|
14. |
劉坤, 羅軍, 婁繁, 等. 大鼠骨髓基質細胞的體外培養和鑒定 [J]. 中國普外基礎與臨床雜志, 2009, 16(11): 875879..
|
15. |
Di FM, Coleoni AH, Pellizas CG, et al. Triiodothyronine induces proliferation in cultured bovine thyroid cells: evidence for the involvement of epidermal growth factorassociated tyrosine kinase activity [J]. J Endocrinol, 2000, 166(1): 173182.
|
16. |
黃穎泓, 楊立勇. 人甲狀腺細胞體外培養的研究進展 [J]. 醫學綜述, 2009, 15(10): 14551458..
|
17. |
Visser TJ. The elemental importance of sufficient iodine intake: a trace is not enough [J]. Endocrinology, 2006, 147(5): 20952097.
|
18. |
Mazzaferri EL, Robbins RJ, Spencer CA, et al. A consensus report of the role of serum thyroglobulin as a monitoring method for lowrisk patients with papillary thyroid carcinoma [J]. J Clin Endocrinol Metab, 2003, 88(4): 14331441.
|
19. |
Miyauchi A, Kudo T, Miya A, et al. Prognostic impact of serum thyroglobulin doublingtime under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy [J]. Thyroid, 2011, 21(7): 707716.
|
20. |
陳佳瑞, 王家東. 橋本甲狀腺炎合并甲狀腺乳頭狀癌外科診治(附51例臨床分析) [J]. 臨床耳鼻咽喉頭頸外科雜志, 2010, 24(6): 257260.
|
21. |
Hartl DM, Al GA, Chami L, et al. High rate of multifocality and occult lymph node metastases in papillary thyroid carcinoma arising in thyroglossal duct cysts [J]. Ann Surg Oncol, 2009, 16(9): 25952601.
|
22. |
莫祥蘭, 黃振錄, 周祥禎, 等. 高分子量角蛋白和TPO在甲狀腺乳頭狀癌診斷中的價值 [J]. 中國實驗診斷學, 2006, 10(6): 585587..
|
23. |
Müller K, Krohn K, Eszlinger M, et al. Effect of iodine on early stage thyroid autonomy [J]. Genomics, 2011, 97(2): 94100.
|
24. |
Faggiano A, Severino R, Ramundo V, et al. Thyroid function in fabry disease before and after enzyme replacement therapy [J]. Minerva Endocrinol, 2011, 36(1): 15.
|
25. |
Ott J, Promberger R, Kober F, et al. Hashimoto’s thyroiditis affects symptom load and quality of life unrelated to hypothyroidism: a prospective casecontrol study in women undergoing thyroidectomy for benign goiter [J]. Thyroid, 2011, 21(2): 161167.
|